IL148275A0 - Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors - Google Patents

Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors

Info

Publication number
IL148275A0
IL148275A0 IL14827500A IL14827500A IL148275A0 IL 148275 A0 IL148275 A0 IL 148275A0 IL 14827500 A IL14827500 A IL 14827500A IL 14827500 A IL14827500 A IL 14827500A IL 148275 A0 IL148275 A0 IL 148275A0
Authority
IL
Israel
Prior art keywords
oxdiazol
alkoxy
ones
phenyl
substituted
Prior art date
Application number
IL14827500A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL148275A0 publication Critical patent/IL148275A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14827500A 1999-09-04 2000-08-22 Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors IL148275A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (1)

Publication Number Publication Date
IL148275A0 true IL148275A0 (en) 2002-09-12

Family

ID=7920884

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14827500A IL148275A0 (en) 1999-09-04 2000-08-22 Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors
IL148275A IL148275A (en) 1999-09-04 2002-02-20 Substituted 3 - phenyl-5-alkoxy- 1,3,4 - oxadiazol- 2 - ones and their use for the manufacture of a medicament having an inhibitory effect on the hormone sensitive lipase

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148275A IL148275A (en) 1999-09-04 2002-02-20 Substituted 3 - phenyl-5-alkoxy- 1,3,4 - oxadiazol- 2 - ones and their use for the manufacture of a medicament having an inhibitory effect on the hormone sensitive lipase

Country Status (30)

Country Link
US (1) US6596742B1 (zh)
EP (1) EP1214302B1 (zh)
JP (1) JP2003508522A (zh)
KR (1) KR100723817B1 (zh)
CN (1) CN1152024C (zh)
AR (1) AR032430A1 (zh)
AT (1) ATE253059T1 (zh)
AU (1) AU781330B2 (zh)
BR (1) BR0013765A (zh)
CA (1) CA2383731A1 (zh)
CZ (1) CZ2002772A3 (zh)
DE (2) DE19942354A1 (zh)
DK (1) DK1214302T3 (zh)
EE (1) EE04811B1 (zh)
ES (1) ES2204685T3 (zh)
HK (1) HK1048318B (zh)
HR (1) HRP20020187A2 (zh)
HU (1) HUP0202988A3 (zh)
IL (2) IL148275A0 (zh)
MX (1) MXPA02001834A (zh)
NO (1) NO323129B1 (zh)
NZ (1) NZ517551A (zh)
PL (1) PL197314B1 (zh)
PT (1) PT1214302E (zh)
RU (1) RU2265600C2 (zh)
SK (1) SK285924B6 (zh)
TR (1) TR200200553T2 (zh)
WO (1) WO2001017981A1 (zh)
YU (1) YU10402A (zh)
ZA (1) ZA200201594B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
AU2005295788A1 (en) * 2004-10-13 2006-04-27 Wyeth N-benzenesulfonyl substituted anilino-pyrimidine analogs
CN101821227A (zh) * 2007-07-12 2010-09-01 德维里斯公司 激素敏感性脂酶调节剂及使用方法
WO2009084970A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Companhia, S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
WO2010074587A2 (en) 2008-12-23 2010-07-01 Bial - Portela & Ca., S.A. 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
EP0067471B1 (en) 1981-06-15 1985-11-06 Shell Internationale Researchmaatschappij B.V. 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
TR200200553T2 (tr) 2002-06-21
YU10402A (sh) 2004-11-25
CN1152024C (zh) 2004-06-02
NO20021007D0 (no) 2002-02-28
HUP0202988A2 (hu) 2002-12-28
JP2003508522A (ja) 2003-03-04
KR100723817B1 (ko) 2007-06-04
CN1371369A (zh) 2002-09-25
WO2001017981A1 (de) 2001-03-15
NZ517551A (en) 2003-10-31
EP1214302A1 (de) 2002-06-19
PT1214302E (pt) 2004-03-31
HK1048318B (zh) 2004-12-10
ZA200201594B (en) 2003-04-30
ATE253059T1 (de) 2003-11-15
HRP20020187A2 (en) 2004-02-29
AU781330B2 (en) 2005-05-19
HK1048318A1 (en) 2003-03-28
SK3012002A3 (en) 2002-06-04
KR20020024336A (ko) 2002-03-29
NO20021007L (no) 2002-02-28
BR0013765A (pt) 2002-04-30
EE04811B1 (et) 2007-04-16
CA2383731A1 (en) 2001-03-15
SK285924B6 (sk) 2007-11-02
DE50004274D1 (de) 2003-12-04
AU7411200A (en) 2001-04-10
DE19942354A1 (de) 2001-03-08
RU2265600C2 (ru) 2005-12-10
IL148275A (en) 2008-08-07
MXPA02001834A (es) 2002-08-12
EP1214302B1 (de) 2003-10-29
PL353214A1 (en) 2003-11-03
EE200200109A (et) 2003-06-16
PL197314B1 (pl) 2008-03-31
ES2204685T3 (es) 2004-05-01
NO323129B1 (no) 2007-01-08
AR032430A1 (es) 2003-11-12
US6596742B1 (en) 2003-07-22
HUP0202988A3 (en) 2004-12-28
CZ2002772A3 (cs) 2002-05-15
DK1214302T3 (da) 2004-02-16

Similar Documents

Publication Publication Date Title
GB9900416D0 (en) Inhibitors
IL148614A0 (en) Pteridinones as kinase inhibitors
IL145764A0 (en) Pyrazolobenzodiazepines as cdk2 inhibitors
MXPA02005067A (es) Composicion inhibidora de la corrosion.
IL150114A0 (en) Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
IL148275A0 (en) Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors
EG22187A (en) New composition
ZA200110053B (en) Factor via inhibitors.
EP1153022A4 (en) PROTEASE INHIBITORS
GB9924522D0 (en) Enzyme inhibitors
HU9903937D0 (en) Objective
GB9919683D0 (en) Composition
AP2001002273A0 (en) Rescorcinol composition
PL353372A1 (en) Substituted heterocyclyl-2h-chromenes
GB2389113B (en) B-secretase inhibitor
ZA200109120B (en) Use of Arylalkanoylpyridazines.
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
SI1214302T1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
EP1175834A4 (en) METHOD OF USING BACTERICIDE COMPOSITION
GB0029300D0 (en) Composition
GB9900413D0 (en) Inhibitors
GB9929341D0 (en) Inhibitors
GB9929340D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors

Legal Events

Date Code Title Description
FF Patent granted